Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSO-ABLE: Enstilar vs Cal/BDP Gel in Psoriasis
NCT02132936Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Jun 2014
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of AKP01, betamethasone dipropionate spray 0.05% in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started Jun 2014; status: completed.
02
Drugs
AKP01betamethasone dipropionate spray 0.05%
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT02132936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132936.